Ionis Pharmaceuticals, Inc. (IONS) NASDAQ

42.69

-0.545(-1.26%)

Updated at August 22 04:00PM

Currency In USD

Valuation

Market Cap5.23B
Enterprise Value6.94B
P/E Ratio-25.33
PEG Ratio-0.62
Price/Sales Ratio7.21
Price/Book Ratio10.75
Enterprise/Revenue8.98
Enterprise/EBITDA-45.01

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.28
Operating Margin-0.28

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.45

Income Statement

Revenue705.14M
Revenue/Share5.93
Gross Profit693.92M
EBITDA-475.08M
Net Income-453.9M
Diluted EPS-3.04

Balance Sheet

Total Cash2.29B
Total Cash/Share14.41
Total Debt1.97B
Total Debt/Equity3.13
Current Ratio2.87
Book Value Per Share3.97

Price History

52-Week Change-10.2
52-Week High50.43
52-Week Low23.95
Moving Average 50 Days41.07
Moving Average 200 Days35.3

Statistics

Average Volume1.92M
Shares Outstanding159.39M
% Held by Institutions106.57

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A